BackSeelos Therapeutics Overview

Seelos Therapeutics Net Income

Profitability analysis for SEEL.

Quarterly Net Income

$1.71M
105.8% YoY

As of Jun 2024

Annual Net Income (TTM)

$4.09M
104.67% YoY

Trailing 12 months ending Jun 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...